Qi Yu

2.6k total citations
104 papers, 1.7k citations indexed

About

Qi Yu is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Qi Yu has authored 104 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Reproductive Medicine, 31 papers in Public Health, Environmental and Occupational Health and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Qi Yu's work include Reproductive Biology and Fertility (22 papers), Estrogen and related hormone effects (21 papers) and Menopause: Health Impacts and Treatments (21 papers). Qi Yu is often cited by papers focused on Reproductive Biology and Fertility (22 papers), Estrogen and related hormone effects (21 papers) and Menopause: Health Impacts and Treatments (21 papers). Qi Yu collaborates with scholars based in China, United States and Germany. Qi Yu's co-authors include Mengxia Ji, Zaixin Guo, Zhengyi Sun, Ruoyun Tan, Jingjing Wu, Danhua Pu, Ruiyi Tang, Ying Li, Yang Xia and Harald Seeger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of neurosurgery and Frontiers in Immunology.

In The Last Decade

Qi Yu

99 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Yu China 20 459 408 357 345 293 104 1.7k
Gloria Bonaccorsi Italy 22 296 0.6× 415 1.0× 159 0.4× 216 0.6× 172 0.6× 74 1.7k
Areti Augoulea Greece 20 520 1.1× 135 0.3× 220 0.6× 405 1.2× 145 0.5× 86 1.5k
Stefano Lello Italy 19 257 0.6× 156 0.4× 229 0.6× 384 1.1× 245 0.8× 67 1.1k
T. J. de Villiers South Africa 19 239 0.5× 208 0.5× 199 0.6× 910 2.6× 761 2.6× 38 1.7k
Salvatore Longobardi Italy 28 968 2.1× 600 1.5× 920 2.6× 797 2.3× 207 0.7× 73 2.6k
Marija Pfeifer Slovenia 24 1.0k 2.2× 378 0.9× 532 1.5× 1.4k 4.1× 158 0.5× 63 2.7k
Federica Barbagallo Italy 30 579 1.3× 973 2.4× 337 0.9× 343 1.0× 195 0.7× 111 2.3k
Lauren Nathan United States 18 184 0.4× 246 0.6× 321 0.9× 881 2.6× 742 2.5× 26 2.2k
Franca Fruzzetti Italy 29 1.1k 2.4× 435 1.1× 988 2.8× 702 2.0× 242 0.8× 106 2.2k
Manubai Nagamani United States 28 864 1.9× 481 1.2× 573 1.6× 785 2.3× 651 2.2× 102 2.7k

Countries citing papers authored by Qi Yu

Since Specialization
Citations

This map shows the geographic impact of Qi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Yu more than expected).

Fields of papers citing papers by Qi Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Yu. The network helps show where Qi Yu may publish in the future.

Co-authorship network of co-authors of Qi Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Yu. A scholar is included among the top collaborators of Qi Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Yu. Qi Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Ximei, Lin Jiang, Le Shi, et al.. (2025). Modulation of brain oscillations by continuous theta burst stimulation in patients with insomnia. Translational Psychiatry. 15(1). 416–416. 1 indexed citations
2.
Dong, Qi, Yanan Wu, Jingxuan Liu, et al.. (2025). Baricitinib for Takayasu arteritis refractory to TNF-α inhibitors: a multicentre, single-arm trial. Lara D. Veeken. 64(10). 5262–5268.
3.
4.
Tang, Ruiyi, Xiangyan Ruan, Mulan Ren, et al.. (2025). Changes in menopause-specific quality of life between women with transdermal estradiol versus oral estrogens: results of a randomized controlled trial. Gynecological Endocrinology. 41(1). 2484213–2484213. 1 indexed citations
5.
Lin, Lin, et al.. (2024). Exploring menopausal symptoms, attitudes, and behaviors among menopausal women in China: an online research perspective. Menopause The Journal of The North American Menopause Society. 31(11). 1006–1013. 3 indexed citations
6.
Wang, Jia, Qi Yu, Sheng‐Xiao Zhang, et al.. (2024). Risk factors for type 2 diabetes mellitus in Chinese rheumatoid arthritis patients from 2018 to 2022: a real-world, single-center, retrospective study. Frontiers in Immunology. 15. 1445639–1445639. 1 indexed citations
7.
Kong, Lingjun, Qi Yu, Ziyi Wang, et al.. (2024). Analytical Performance of a Novel Nanopore Sequencing for SARS‐CoV‐2 Genomic Surveillance. Journal of Medical Virology. 96(12). e70108–e70108. 1 indexed citations
8.
Chen, Shuwen, Zaixin Guo, Ying Tian, et al.. (2023). Down‐regulation of Lon protease 1 lysine crotonylation aggravates mitochondrial dysfunction in polycystic ovary syndrome. SHILAP Revista de lepidopterología. 4(5). e396–e396. 7 indexed citations
9.
Tang, Ruhang, Zhibo Xie, Xiangyan Ruan, et al.. (2023). Changes in menopausal symptoms comparing oral estradiol versus transdermal estradiol. Climacteric. 27(2). 171–177. 3 indexed citations
10.
11.
Downes, Martin, Tommaso Simoncini, Qi Yu, et al.. (2023). Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China. Journal of Medical Economics. 27(1). 16–26. 3 indexed citations
12.
Chen, Shuwen, Zaixin Guo, & Qi Yu. (2023). Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome. Human Genomics. 17(1). 100–100. 1 indexed citations
13.
Wang, Ziran, Qi Yu, Yiwei Liu, et al.. (2023). Performance evaluation of QuantStudio 1 plus real-time PCR instrument for clinical laboratory analysis: A proof-of-concept study. Practical Laboratory Medicine. 36. e00330–e00330. 2 indexed citations
14.
Sun, Zhengyi, et al.. (2023). Impact of endometriosis on embryo quality and endometrial receptivity in women undergoing assisted reproductive technology. Reproductive Biology. 23(2). 100733–100733. 5 indexed citations
15.
Guo, Zaixin, et al.. (2021). A Comprehensive Analysis of the Downregulation of miRNA-1827 and Its Prognostic Significance by Targeting SPTBN2 and BCL2L1 in Ovarian Cancer. Frontiers in Molecular Biosciences. 8. 687576–687576. 10 indexed citations
16.
Tao, Huai, et al.. (2020). Elevated Serum Matrix Metalloproteinase-9, Interleukin-6, Hypersensitive C-Reactive Protein, and Homocysteine Levels in Patients with Epilepsy. Journal of Interferon & Cytokine Research. 40(3). 152–158. 17 indexed citations
17.
Yu, Qi, et al.. (2018). Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study. International Journal of Women s Health. Volume 10. 257–266. 3 indexed citations
18.
Yu, Qi, Yingfang Zhou, Л. В. Сутурина, et al.. (2018). Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial. Journal of Women s Health. 27(10). 1225–1232. 9 indexed citations
19.
Yu, Qi, Shulan Zhang, Huajun Li, et al.. (2018). Dienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension Study. Journal of Women s Health. 28(2). 170–177. 17 indexed citations
20.
Neubauer, Hans, Rong Chen, H Schneck, et al.. (2011). New insight on a possible mechanism of progestogens in terms of breast cancer risk. Hormone Molecular Biology and Clinical Investigation. 6(1). 185–192. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gloria Bonaccorsi Breakdown of academic impact, for papers by Areti Augoulea Breakdown of academic impact, for papers by Stefano Lello Breakdown of academic impact, for papers by T. J. de Villiers Breakdown of academic impact, for papers by Salvatore Longobardi Breakdown of academic impact, for papers by Marija Pfeifer Breakdown of academic impact, for papers by Federica Barbagallo Breakdown of academic impact, for papers by Lauren Nathan Breakdown of academic impact, for papers by Franca Fruzzetti Breakdown of academic impact, for papers by Manubai Nagamani
Rankless by CCL
2026